At Celiac Disease Foundation’s National Conference on April 30, 2016, the “Dine with the Dietitians” session provided simplified guidelines for the gluten-free diet for those with celiac disease and gluten sensitivity. Janelle Smith, CDF’s Registered Dietitian, shared a panel with Emily Luxford, RD, Celiac Disease Foundation Board of Directors, Scott Mandell, CEO of Enjoy Life […]
Pediatric Celiac Disease Follow-Up Checklist
We fight to improve the lives of all people affected by celiac disease and non-celiac wheat sensitivity now
Are you still learning the ins and outs of celiac disease? Do you feel overwhelmed with all of the information? Celiac Disease Foundation has the perfect resource for you. Our Celiac Disease Fast Facts include important truths and details about living with celiac disease and the gluten-free diet. The CDF Fast Facts discusses how to […]
Last year, Celiac Disease Foundation (CDF) partnered with the North American Society for the Study of Celiac Disease (NASSCD) to award a three-year, $150,000 grant to support young investigator research in finding the cause and treatment for celiac disease. We are pleased to announce that NASSCD is now accepting applications for the Young Investigator Award for Celiac […]
Are you interested in advancing research toward treatment and a cure for celiac disease? The University of Chicago Celiac Disease Center is enrolling patients for a clinical study testing the effectiveness of a pill for celiac disease. CDF is proud to support the efforts of Medical Advisory Board member, Stefano Guandalini, MD, and CDF Research […]
It is common for those with celiac disease to turn to over-the-counter (OTC) or prescription loperamide (brand name: Imodium) for short-term treatment of diarrhea. The FDA has recently issued a warning that overuse of this medication can lead to serious cardiac issues, and even death. Users of loperamide are encouraged to adhere to recommended dosages […]
With more than 1,200 participants registered in its first four months, iCureCeliac™ is shaping the type of research that is most important to you – the patient. We are pleased to present a few initial findings.